IDEXX Laboratories Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, IDEXX Laboratories stock has a consensus rating of "Buy" and an average price target of $698.92. The average 1-year stock price forecast is 25.50% higher than the current stock price, while the lowest is $470 (-15.61%) and the highest is $805 (+44.54%).

Price Target: $698.92 (+25.50%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$470	$698.92	$700	$805
Change	-15.61%	+25.50%	+25.69%	+44.54%

Analyst Ratings

The average analyst rating for IDEXX Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	5	5	5	5	5	4
Buy	4	4	4	4	4	4
Hold	5	5	5	5	5	5
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	15	15	15	15	15	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Ryskin Bank of America Securities	Bank of America Securities	Hold Maintains $660 → $665	Hold	Maintains	$660 → $665	+19.40%	Aug 14, 2026
Jonathan Block Stifel Nicolaus	Stifel Nicolaus	Buy Reiterates $675	Buy	Reiterates	$675	+21.20%	Aug 14, 2026
Ryan Daniels William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Aug 13, 2026
Glen Santangelo Barclays	Barclays	Buy Maintains $710	Buy	Maintains	$710	+27.48%	Aug 11, 2026
Erin Wright Morgan Stanley	Morgan Stanley	Buy Maintains $805	Buy	Maintains	$805	+44.54%	Aug 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

4.72B

from 4.30B

9.77%

from 4.30B

Revenue Next Year

5.14B

from 4.72B

8.81%

from 4.72B

EPS This Year

14.83

from 13.08

13.42%

from 13.08

EPS Next Year

16.74

from 14.83

12.84%

from 14.83

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	3.22B	3.37B	3.66B	3.90B	4.30B	4.72B
Revenue Growth	18.80%	4.73%	8.72%	6.46%	10.42%	9.77%
Gross Profit	1.89B	2.00B	2.19B	2.38B	2.66B	2.96B
Gross Margin	58.76%	59.52%	59.82%	61.04%	61.80%	62.69%
Operating Income	932.03M	898.77M	1.10B	1.19B	1.36B	1.53B
Net Income	744.85M	679.09M	845.04M	887.87M	1.06B	1.18B
EPS	-	-	-	-	13.08	14.83
EPS Growth	-	-	-	-	22.59%	13.42%
Forward PE	73.77	44.25	51.93	35.35	48.03	37.54
Free Cash Flow	534.41M	328.16M	693.69M	734.99M	790.74M	1.18B
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	4.7B
Avg	4.7B
Low	4.7B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	10.3%
Avg	9.8%
Low	9.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	15.18
Avg	14.83
Low	14.46

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	16.0%
Avg	13.4%
Low	10.6%